中国当代医药
中國噹代醫藥
중국당대의약
China Modern Medicine
2015年
25期
45-47
,共3页
陈旭昌%王进%刘秀丽%侯美娜
陳旭昌%王進%劉秀麗%侯美娜
진욱창%왕진%류수려%후미나
葡萄糖-胰岛素-钾盐(极化液)%1,6-二磷酸果糖%射血分数正常心力衰竭
葡萄糖-胰島素-鉀鹽(極化液)%1,6-二燐痠果糖%射血分數正常心力衰竭
포도당-이도소-갑염(겁화액)%1,6-이린산과당%사혈분수정상심력쇠갈
Glucose-insulin-sylvite (polarized solution)%FDP%Heart failure with normal ejection fraction
目的:探讨镁极化液(Mg-GIK)与1,6-二磷酸果糖(FDP)治疗射血分数正常心力衰竭(HFNEF)的临床效果。方法选取2009年6月~2013年12月在我院住院的HFNEF患者90例,随机分为两组,对照组给予利尿剂、ACEI、硝酸酯类等药物常规治疗;治疗组在常规治疗基础上加用Mg-GIK与FDP治疗,10 d为1个疗程。结果治疗组与对照组心功能改善总有效率分别为86.7%、62.2%,两组比较,差异有统计学意义(P<0.05)。随访3个月,两组再住院率比较差异无统计学意义(P>0.05)。结论Mg-GIK与FDP治疗HFNEF能明显改善患者的心功能。
目的:探討鎂極化液(Mg-GIK)與1,6-二燐痠果糖(FDP)治療射血分數正常心力衰竭(HFNEF)的臨床效果。方法選取2009年6月~2013年12月在我院住院的HFNEF患者90例,隨機分為兩組,對照組給予利尿劑、ACEI、硝痠酯類等藥物常規治療;治療組在常規治療基礎上加用Mg-GIK與FDP治療,10 d為1箇療程。結果治療組與對照組心功能改善總有效率分彆為86.7%、62.2%,兩組比較,差異有統計學意義(P<0.05)。隨訪3箇月,兩組再住院率比較差異無統計學意義(P>0.05)。結論Mg-GIK與FDP治療HFNEF能明顯改善患者的心功能。
목적:탐토미겁화액(Mg-GIK)여1,6-이린산과당(FDP)치료사혈분수정상심력쇠갈(HFNEF)적림상효과。방법선취2009년6월~2013년12월재아원주원적HFNEF환자90례,수궤분위량조,대조조급여이뇨제、ACEI、초산지류등약물상규치료;치료조재상규치료기출상가용Mg-GIK여FDP치료,10 d위1개료정。결과치료조여대조조심공능개선총유효솔분별위86.7%、62.2%,량조비교,차이유통계학의의(P<0.05)。수방3개월,량조재주원솔비교차이무통계학의의(P>0.05)。결론Mg-GIK여FDP치료HFNEF능명현개선환자적심공능。
Objective To explore the clinical effect of Mg-GIK combined with FDP treating heart failure with normal ejection fraction (HFNEF). Methods 90 patients with HFNEF hospitalized in our hospital from June 2009 to December 2013 were selected.Patients were randomly divided into two groups.Control group was given routine drugs therapy such as diuretic,ACEI and nitrate esters.On the basis of control group,treatment group was given Mg-GIK combined with FDP,and a course of treatment was 10 days. Results The total rate of heart function improvement in treatment group and control group was 86.7% and 62.2% respectively,and the difference was statistical significance (P<0.05).Patients were followed-up for 3 months,the rehospitalization rate between two groups had no statistical difference (P>0.05). Conclusion Mg-GIK combined with FDP treating HFNEF can significantly improve heart function of patients.